BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 6243164)

  • 1. Pharmacologic antagonism of beta adrenergic blockade in dogs. II. Hemodynamic effects of simultaneous intravenous infusion of isoproterenol and dopamine during chronic propranolol administration.
    Spotnitz HM; Avery GJ; Rose EA; Benvenisty AI; Malm JR; Hoffman BF
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):103-8. PubMed ID: 6243164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic antagonism of beta-adrenergic blockade in dogs. I. Hemodynamic effects of isoproterenol, dopamine, and epinephrine in acute propranolol administration.
    Avery GJ; Spotnitz HM; Rose EA; Malm JR; Hoffman BF
    J Thorac Cardiovasc Surg; 1979 Feb; 77(2):267-76. PubMed ID: 33298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic antagonism of propranolol in dogs. III. Effects of dopamine-isoproterenol and glucagon on hemodynamics and myocardial oxygen consumption in ischemic hearts during chronic propranolol administration.
    Wei J; Spotnitz HM; Spotnitz WD; Benvenisty AI; Haasler GB; Malm JR; Hoffman BF
    J Thorac Cardiovasc Surg; 1984 May; 87(5):732-42. PubMed ID: 6717051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on heart failure in old age (Part II). Hemodynamic effects of propranolol and isoproterenol in elderly patients with heart failure.
    Mifune J
    Jpn Circ J; 1978 Sep; 42(9):1065-7, 1073-80. PubMed ID: 731844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of chronic canine beta-adrenergic blockade with dopamine-isoproterenol, dobutamine, and glucagon.
    Benvenisty AI; Spotnitz HM; Rose EA; Malm JR; Hoffman BF
    Surg Forum; 1979; 30():187-8. PubMed ID: 538590
    [No Abstract]   [Full Text] [Related]  

  • 6. Beta-adrenergic drug therapy in newborn canine endotoxic shock.
    Goto M; Griffin AJ; Chiemmongkoltip P; Ohya N
    Circ Shock; 1990 Oct; 32(2):123-32. PubMed ID: 1979257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Action of a sodium lactate perfusion on the hemodynamic effects of beta-blockaders].
    Scebat A; Castan L; Renais R; Chiche J; Fernandez F; Gerbaux A
    Arch Mal Coeur Vaiss; 1978 Mar; 71(3):306-13. PubMed ID: 25055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of beta-adrenergic blockade on the cardiovascular response to diltiazem or verapamil in dogs.
    Sullivan KB; Kapur PA
    Anesth Analg; 1986 Nov; 65(11):1099-106. PubMed ID: 3021022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.
    Hansson L
    Acta Med Scand Suppl; 1973; 550():1-40. PubMed ID: 4201751
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cardiodynamics of the conscious dog undergoing treadmill exercise, blood pressure reduction or isoproterenol and its modification by beta-blockade].
    Lehmann HD
    Dtsch Tierarztl Wochenschr; 1985 Apr; 92(4):135-9. PubMed ID: 3899576
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol.
    Bodem G; Brammell HL; Weil JV; Chidsey CA
    J Clin Invest; 1973 Apr; 52(4):747-54. PubMed ID: 4144332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cardiovascular actions of dopamine and the effects of central and peripheral catecholaminergic receptor blocking drugs.
    Setler PE; Pendleton RG; Finlay E
    J Pharmacol Exp Ther; 1975 Mar; 192(3):702-12. PubMed ID: 1120964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo cardiovascular responses to isoproterenol, dopamine and tyramine after prolonged infusion of isoproterenol.
    Hayes JS; Pollock GD; Fuller RW
    J Pharmacol Exp Ther; 1984 Dec; 231(3):633-9. PubMed ID: 6094797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 1-(4-nitrophenyl)-2-isopropylaminoethanol (INPEA) and propranolol and their dextro-isomers on hemodynamic and metabolic responses to isoproterenol in dogs.
    Nishimura T; Kita S; Abiko Y
    J Pharmacol Exp Ther; 1983 Aug; 226(2):595-602. PubMed ID: 6688273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of cholecystokinin (CCK-8) with agonist and antagonist of beta-adrenergic receptors in circulatory system of diabetic rats.
    Wiśniewska RJ; Wiśniewski K
    Pol J Pharmacol; 1996; 48(3):293-7. PubMed ID: 9112665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo interaction of AR-L 115BS (Vardax) with the adrenergic nervous system.
    Petein M; Pierpont GL; Francis GS; Cohn JN; From AH
    J Cardiovasc Pharmacol; 1984; 6(6):1020-6. PubMed ID: 6084757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aortic peak flow velocity as an index of myocardial contractility in the conscious rat.
    Dowell RT; Houdi AA
    Methods Find Exp Clin Pharmacol; 1997 Oct; 19(8):533-9. PubMed ID: 9442476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic responses to dopamine infusion at controlled normal and low cardiac output states in the anesthetized dog.
    Gooding JM; Karp RB; Appelbaum A; Tracy WG
    J Thorac Cardiovasc Surg; 1977 May; 73(5):758-62. PubMed ID: 850435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic propranolol treatment decreases pulmonary artery pressure in conscious dogs.
    Voelkel NF; Walker BR; Reeves JT
    Clin Physiol Biochem; 1984; 2(4):176-83. PubMed ID: 6488695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparative hemodynamic effects of propranolol in chronically instrumented puppies and adult dogs.
    Driscoll DJ; Fukushige J; Lewis RM; Hartley CJ; Entman MJ
    Biol Neonate; 1982; 41(1-2):8-15. PubMed ID: 7066441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.